$LLLI: Lamperd Less Lethal Receives Follow-Up Orders from

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
311
$LLLI: Lamperd Less Lethal Receives Follow-Up Orders from Talion Defense Corp. for Components of Advanced Riot Control Munitions to be Manufactured in the USA

Talion Performing Assembly and Arming of Lamperd Designed Products for Marketing to US Police and Corrections Agencies


Link: https://www.otcmarkets.com/filing/html?id=154...FniGBAxOth

SARNIA, ON / December 21, 2021 / Lamperd Less Lethal, Inc. (OTC PINK: LLLI), an innovation leader and manufacturer of advanced security solutions for law enforcement, military and security agencies worldwide, has received follow-up orders from its new Colorado based manufacturer and sales distributor, Talion Defense Corp. (https://www.taliondefense.com).

As with Talion’s initial order in November, Lamperd will supply components of its advanced riot control munitions intended for US police and corrections agencies with which Talion has established relationships. Since Talion imports only inert components of the Lamperd products into the US, this arrangement greatly reduces regulatory issues. Talion performs assembly and arming these components at its own facility to be sold as finished Talion Defense Corp. products. These products can therefore be labeled as “Made in Colorado, USA” making them more appropriate for US buyers.

Oliver Mazurkiewicz, Talion's Agency Sales Lead noted: "We are seeing a great deal of excitement for these less lethal products in the US market and are going to be holding a series of multi-agency demos in January of 2022. We believe the Lamperd products bring a proven quality option to what is certainly a significant agency need."

Barry Lamperd, CEO of Lamperd Less Lethal stated, “We are very impressed by the diligent efforts of our new business associates at Talion to quicky set up their manufacturing and sales operation for Lamperd designed security products in the vast US marketplace. With all the crisis situations happening in the US today, and the demands to find more effective less lethal response products, we foresee a major opportunity for sales growth. Talion is giving us just the presence to grow our market share in the USA at this time when it is needed most. Lamperd products have been extensively developed and tested to be the most effective and also the safest in the less lethal industry so they can be of great help in maintaining order and helping to save more lives.”

For information on purchasing these US-made products, please contact the Agency Sales Team of Talion Defense at info@taliondefense.com or (970) 344-5667.

About Lamperd Less Lethal:

Lamperd Less Lethal, Inc. (LLLI) is a developer, manufacturer and international sales company for advanced less lethal weapons, ammunition and other security products marketed to police, correctional, military and private security forces. The company manufactures and sells over 300 different products including small & large caliber projectile guns, flash-bang devices, pepper spray devices, 37mm & 40mm launching systems and interlocking riot shields. Lamperd also offers advisory services and hands-on training classes run by highly accredited instructors.


For more information visit: http://www.lamperdlesslethal.com.


This press release contains forward-looking statements relating to Lamperd Less Lethal, Inc. Lamperd Less Lethal, Inc. undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results.Safe Harbor for Forward-Looking Statements:This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact: Lamperd Less Lethal, Inc.

Barry Lamperd, President & CEO

(519) 344-4445

Email: info@lamperdlesslethal.com or sales@lamperdlesslethal.com

Company Website: http://www.lamperdlesslethal.com

Lamperd Less Lethal on Facebook: https://www.facebook.com/lamperdlesslethal


Lamperd Less Lethal on Instagram: https://www.instagram.com/llli_lamperd_lesslethal

Lamperd Less Lethal on Twitter: https://www.twitter.com/LLLI_LessLethal

Barry Lamperd on Twitter: https://www.twitter.com/lamperd_llli
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 225

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 242

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 135

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 222

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Bouygues Enhances Shareholder Value Through Buyback Actions

Updated Category News Views 74

Bouygues Boosts Shareholder Value with Buyback Initiatives In corporate finance, share buybacks are often adopted as a strategic way to strengthen shareholder trust and increase stock value. Recently, Bouygues SA's trading activities have shown their dedication to creating value and aligning with the interests of their shareholders. Summary of Recent Buyback Activities...

Continue Reading
Warren Buffett's Investment in Occidental Faces Major Setback

Updated Category News Views 61

Warren Buffett's Investment Challenges with Occidental Petroleum Recently, Occidental Petroleum's shares dropped by 29% since mid-April, which has a direct impact on Warren Buffett’s large investment in the company. This decline raises concerns about potential strategies for future investments. Investment Context and Current Situation Chris Bloomstran, an experienced...

Continue Reading
Datavault AI Boosts WiSA Technology for Enhanced Home Audio

Updated Category News Views 275

Enhancing Audio Experience with Datavault AI's Innovations In the ever-evolving world of audio technology, Datavault AI has made significant strides to enhance the home audio experience. Through its Acoustic Science Division's Wireless Sound Association (WiSA), the company has launched several cutting-edge solutions designed to elevate audio quality while maintaining...

Continue Reading
Turkey Central Bank's Recent Interest Rate Reduction Explained

Updated Category News Views 297

Turkey's Central Bank Interest Rate Adjustment The central bank of Turkey has recently made headlines by announcing a significant reduction in its interest rate for the second consecutive time. This move is primarily attributed to a more pronounced slowdown in inflation that has taken place recently. Rate Cut Details The Monetary Policy Committee, led by the governor, has...

Continue Reading
Embracing Inclusivity: The Proud Pair Jewelry Initiative

Updated Category News Views 350

Embracing Inclusivity: The Proud Pair Jewelry Initiative In a significant step towards inclusivity, Hong Kong Marriage Equality has joined forces with the innovative local jewellery brand Playback Concept to unveil the "Proud Pair" collection. This unique initiative reimagines traditional jewellery by incorporating essential motifs that resonate with diverse gender...

Continue Reading